Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Truffle Capital Raises €250M For New BioMedtech VC Fund

Dec 18 2019

• By Catherine Longworth

Euro currency

Related Content

Symetis TAVR Buy Not About Throwing Shade On Lotus, BSX Insists

Mar 30 2017

Stryker's Deal For Spine Device Maker Vexim Rounds Up Ortho M&A Trilogy

Oct 27 2017

French Start-Up Seals Deal For Harvard's Tissue Repair Tech

Mar 28 2018

Truffle Eyes A Dozen Investments With New BioMedtech Fund

Jan 10 2018

Related Companies

Vexim SA

Stryker Corporation

Boston Scientific Corporation

Additional Topics

Commercial Financing Innovation Dermatology Cardiology Medical Device

More from Business

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window